Oncocyte to Announce Second Quarter 2024 Financial Results on August 8

Core Viewpoint - Oncocyte Corp. will announce its second quarter 2024 financial results on August 8, 2024, followed by a conference call and webcast to discuss the results and highlights [1]. Company Overview - Oncocyte is a diagnostics technology company focused on providing clarity and confidence to physicians and patients through its tests [1]. - The company's key products include: - VitaGraft™, a clinical blood-based solid organ transplantation monitoring test - GraftAssure™, a research use only (RUO) blood-based solid organ transplantation monitoring test - DetermaIO™, a gene expression test assessing the tumor microenvironment to predict response to immunotherapies - DetermaCNI™, a blood-based monitoring tool for therapeutic efficacy in cancer patients [1]. Conference Call Details - The conference call will take place on August 8, 2024, at 5:00 p.m. Eastern Time, with a toll-free dial-in number for participants [1]. - A live webcast will be available on the company's website, and a replay will be accessible shortly after the call concludes [1].